Novel drug approvals
United States, 2024 to 2025
46
2025
Novel drug approvals: United States, 2024 to 2025
Novel drug approvals: United States, 2024 to 2025. 2 observations from 2024 to 2025, ranging from 46 to 50. Latest value 46 (2025).
0
10
20
30
40
50
2024
2025
50
46
Novel drug approvals: United States, 2024 to 2025
Novel drug approvals: United States, 2024 to 2025. 2 observations from 2024 to 2025, ranging from 46 to 50. Latest value 46 (2025).
0
20
40
60
2024
2025
50
46
Novel drug approvals: United States, 2024 to 2025
Novel drug approvals: United States, 2024 to 2025. 2 observations from 2024 to 2025, ranging from 46 to 50. Latest value 46 (2025).
0
20
40
60
2024
2025
50
46
View the underlying data
Novel drug approvals: United States, 2024 to 2025
Period
Type
Value
2024
Actual
50
2025
Actual
46
Chart:
StatOrigin
· Source: FDA ·
statorigin.org
CC BY 4.0